Lodoxamide Tromethamine

洛多酰胺氨基丁三醇

Report date: 2023/02/21 17:29:06
NME

Base Information

Drug NameLodoxamide Tromethamine
Drug Alias Name洛度沙胺氨丁三醇洛草氨酸氨丁三醇AlomideU-42585E
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsConjunctivitis, AllergicConjunctivitis
Global Approved IndicationsConjunctivitis, AllergicConjunctivitis
Approved Indications in ChinaConjunctivitis
Original Approved Country/TerritoryUnited States
Original Approved Date1993/09/23
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Inactive CompaniesNovartis Pharma Ag
Active IndicationsConjunctivitis
Inactive IndicationsConjunctivitis, Allergic

Other Information

ATC CodeS01GX05